Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Brace Treatment for Idiopathic Scoliosis; PReventing Idiopathic SCOliosis PROgression

NCT: NCT04805437 · RECRUITING

NCT IDNCT04805437
StatusRECRUITING
Start Date2021-04-30
Completion2037-04
SponsorKarolinska Institutet (OTHER)
First posted
Last updated

Brief Summary

Idiopathic scoliosis is the most common spinal deformity in children and adolescents with an estimated prevalence of 3%. About one tenth of the children with scoliosis develop a deformity that requires treatment with brace or surgery with the current treatment protocol. When brace treatment for scoliosis is indicated, standard treatment consists of bracing 20 hours or more per day. Outcomes of brace treatment depend to a large extent on wearing time and since many adolescents feel uncomfortable in the brace, it is of importance to combine efficacy and comfortability of the brace.

Frequently Asked Questions

What is Brace Treatment for Idiopathic Scoliosis; PReventing Idiopathic SCOliosis PROgression?

Brace Treatment for Idiopathic Scoliosis; PReventing Idiopathic SCOliosis PROgression is a clinical trial registered under NCT04805437. Current status: RECRUITING.

What is the status of NCT04805437?

The current status of NCT04805437 (Brace Treatment for Idiopathic Scoliosis; PReventing Idiopathic SCOliosis PROgression) is: RECRUITING.

When did Brace Treatment for Idiopathic Scoliosis; PReventing Idiopathic SCOliosis PROgression start?

Brace Treatment for Idiopathic Scoliosis; PReventing Idiopathic SCOliosis PROgression started on 2021-04-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.